Internal Medicine, Cardiovascular Disease · Long Beach, CA
NPI
1841515509
Since 2010
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
2699 Atlantic Ave
Long Beach, CA, 90806
Phone (714) 389-1828
Groups this clinician bills Medicare through
Medicare paid, 2024
$30K
339 services
Medicare patients, 2024
108
Average age 76
Drug cost, 2024
$937K
5,027 prescriptions
Company payments, 2025
$1,015
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Chris W Pan was code 99214 (office e&m - established), 130 times for 77 patients. In total Chris W Pan billed 339 services in 26 codes, and Medicare paid $30K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-12-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 130 | 77 | $99.74 | $13K |
| 93000 Electrocardiogram | Office | 33 | 28 | $11.90 | $393 |
| 93306 Echocardiography (TTE/TEE) | Office | 32 | 30 | $159.20 | $5,095 |
| 99204 Office E&M - New | Office | 16 | 16 | $127.89 | $2,046 |
| 93248 Electrocardiogram | Office | 14 | 11 | $19.35 | $271 |
| 93306 Echocardiography (TTE/TEE) | Facility | 12 | 12 | $56.19 | $674 |
By year: 2022 $31K for 358 services; 2023 $36K for 410 services; 2024 $30K for 339 services.
Medicare prescription drug claims, 2024
In 2024, the drug Chris W Pan prescribed most often to Medicare patients was Metoprolol Succinate, with 534 prescriptions and refills. In total Chris W Pan wrote 5,027 Medicare prescriptions that cost $937K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 534 | 1,549 | 187 | $10K |
| Furosemide Generic | 470 | 1,266 | 153 | $3,183 |
| Atorvastatin Calcium Generic | 383 | 1,109 | 127 | $4,363 |
| Amlodipine Besylate Generic | 352 | 965 | 120 | $2,107 |
| Eliquis Apixaban | 336 | 655 | 87 | $364K |
| Carvedilol Generic | 249 | 712 | 82 | $2,801 |
| Losartan Potassium Generic | 242 | 699 | 85 | $2,547 |
| Entresto Sacubitril/Valsartan | 170 | 320 | 43 | $185K |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 166 | 421 | 55 | $2,292 |
| Farxiga Dapagliflozin Propanediol | 142 | 215 | 28 | $113K |
| Xarelto Rivaroxaban | 131 | 223 | 31 | $117K |
| Lisinopril Generic | 126 | 368 | 42 | $1,026 |
| Clopidogrel Clopidogrel Bisulfate | 119 | 350 | 47 | $1,318 |
| Spironolactone Generic | 99 | 238 | 35 | $872 |
| Hydrochlorothiazide Generic | 99 | 271 | 29 | $424 |
Brand drugs: 950 claims; generic drugs: 4,077 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Chris W Pan $1,015 ($1,015 in general payments such as food, travel and fees) from 12 companies. The largest payer was AOP Health US, LLC with $268.
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 1 | $268 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $199 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $94.44 |
| Scpharmaceuticals Inc. SCPH | 4 | $91.32 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $82.49 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $62.4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $62.3 |
| Lantheus Medical Imaging, Inc. LNTH | 2 | $55.13 |
| Kestra Medical Technology Services, Inc. | 2 | $27.49 |
| BridgeBio Pharma, Inc. BBIO | 1 | $25.39 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.